nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amino acid–anticodon binding specificity: rationale for a new class of therapeutic agent
|
Melzer, Marvin S. |
|
2012 |
17 |
7-8 |
p. 291-295 5 p. |
artikel |
2 |
Can biochemistry drive drug discovery beyond simple potency measurements?
|
Chène, Patrick |
|
2012 |
17 |
7-8 |
p. 388-395 8 p. |
artikel |
3 |
Can we discover pharmacological promiscuity early in the drug discovery process?
|
Peters, Jens-Uwe |
|
2012 |
17 |
7-8 |
p. 325-335 11 p. |
artikel |
4 |
Capillary electrophoresis and small molecule drug discovery: a perfect match?
|
Espada, Alfonso |
|
2012 |
17 |
7-8 |
p. 396-404 9 p. |
artikel |
5 |
Case study: adapting in vitro blood–brain barrier models for use in early-stage drug discovery
|
Vandenhaute, Elodie |
|
2012 |
17 |
7-8 |
p. 285-290 6 p. |
artikel |
6 |
Classification of scaffold-hopping approaches
|
Sun, Hongmao |
|
2012 |
17 |
7-8 |
p. 310-324 15 p. |
artikel |
7 |
Computational models for predicting substrates or inhibitors of P-glycoprotein
|
Chen, Lei |
|
2012 |
17 |
7-8 |
p. 343-351 9 p. |
artikel |
8 |
Contents page 2
|
|
|
2012 |
17 |
7-8 |
p. iii- 1 p. |
artikel |
9 |
Contents page 1
|
|
|
2012 |
17 |
7-8 |
p. i- 1 p. |
artikel |
10 |
Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention
|
Broussalis, Erasmia |
|
2012 |
17 |
7-8 |
p. 296-309 14 p. |
artikel |
11 |
Determinants for successful marketing authorisation of orphan medicinal products in the EU
|
Putzeist, Michelle |
|
2012 |
17 |
7-8 |
p. 352-358 7 p. |
artikel |
12 |
Diverse roles of the scaffolding protein RanBPM
|
Suresh, Bharathi |
|
2012 |
17 |
7-8 |
p. 379-387 9 p. |
artikel |
13 |
Getting the most out of your IP – patent management along its life cycle
|
Bader, Martin A. |
|
2012 |
17 |
7-8 |
p. 281-284 4 p. |
artikel |
14 |
If you want to shoot for the moon, you gotta have the right stuff
|
Bradley, Mary |
|
2012 |
17 |
7-8 |
p. 279-280 2 p. |
artikel |
15 |
Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?
|
Costantino, Luca |
|
2012 |
17 |
7-8 |
p. 367-378 12 p. |
artikel |
16 |
Pharmacological and therapeutic effects of A3 adenosine receptor agonists
|
Fishman, Pnina |
|
2012 |
17 |
7-8 |
p. 359-366 8 p. |
artikel |
17 |
Stem cell technology for drug discovery and development
|
Hook, Lilian A. |
|
2012 |
17 |
7-8 |
p. 336-342 7 p. |
artikel |